{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:28:36Z","timestamp":1789954116227,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008136","name":"Case Western Reserve University","doi-asserted-by":"crossref","award":["T32 GM07250"],"award-info":[{"award-number":["T32 GM07250"]}],"id":[{"id":"10.13039\/100008136","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000009","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI100560"],"award-info":[{"award-number":["R01 AI100560"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI063517"],"award-info":[{"award-number":["R01 AI063517"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.diagmicrobio.2015.02.003","type":"journal-article","created":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T23:36:26Z","timestamp":1423870586000},"page":"65-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single \u03b2-lactamases"],"prefix":"10.1016","volume":"82","author":[{"given":"Krisztina M.","family":"Papp-Wallace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saralee","family":"Bajaksouzian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman M.","family":"Abdelhamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altreisha N.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa L.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian A.","family":"Gatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wright W.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Testa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0005","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1128\/AAC.00848-06","article-title":"Role of Asp104 in the SHV \u03b2-lactamase","volume":"50","author":"Bethel","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0010","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1128\/AAC.42.5.1042","article-title":"A237T as a modulating mutation in naturally occurring extended-spectrum TEM-type \u03b2-lactamases","volume":"42","author":"Blazquez","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0015","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/cid\/cit152","article-title":"10\u00d7'20 Progress\u2013development of new drugs active against Gram-negative bacilli: an update from the Infectious Diseases Society of America","volume":"56","author":"Boucher","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0025","doi-asserted-by":"crossref","first-page":"26603","DOI":"10.1074\/jbc.273.41.26603","article-title":"The role of residue 238 of TEM-1 \u03b2-lactamase in the hydrolysis of extended-spectrum antibiotics","volume":"273","author":"Cantu","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0030","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1128\/AAC.01896-13","article-title":"Contemporary diversity of \u03b2-lactamases among Enterobacteriaceae in the nine U.S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent \u03b2-lactamase groups","volume":"58","author":"Castanheira","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0035","series-title":"Approved standard M7-A10","article-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2015"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0040","series-title":"Twenty-fourth informational supplement M100-S25","article-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2015"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0045","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1128\/AAC.00743-09","article-title":"Penicillin sulfone inhibitors of class D \u03b2-lactamases","volume":"54","author":"Drawz","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0055","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/pro.612","article-title":"Exploring sequence requirements for C(3)\/C(4) carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: insights into plasticity of the AmpC \u03b2-lactamase","volume":"20","author":"Drawz","year":"2011","journal-title":"Protein Sci"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0050","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1128\/AAC.00826-13","article-title":"New \u03b2-lactamase inhibitors: a therapeutic renaissance in an MDR world","volume":"58","author":"Drawz","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0060","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1021\/bi9015549","article-title":"Enhancing resistance to cephalosporins in class C \u03b2-lactamases: impact of Gly214Glu in CMY-2","volume":"49","author":"Endimiani","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0065","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/jac\/dkq207","article-title":"Rapid identification of blaKPC-possessing Enterobacteriaceae by PCR\/electrospray ionization-mass spectrometry","volume":"65","author":"Endimiani","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0070","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1179\/1973947813Y.0000000145","article-title":"Avibactam reverts the ceftazidime MIC90 of European Gram-negative bacterial clinical isolates to the epidemiological cut-off value","volume":"26","author":"Flamm","year":"2014","journal-title":"J Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0080","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/jac\/45.1.101","article-title":"Detrimental effect of the combination of R164S with G238S in TEM-1 \u03b2-lactamase on the extended-spectrum activity conferred by each single mutation","volume":"45","author":"Giakkoupi","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0075","first-page":"37","article-title":"Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in \u03b2-lactam resistance conferred on Escherichia coli","volume":"201","author":"Giakkoupi","year":"2001","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0085","doi-asserted-by":"crossref","first-page":"52724","DOI":"10.1074\/jbc.M306059200","article-title":"Understanding resistance to \u03b2-lactams and \u03b2-lactamase inhibitors in the SHV \u03b2-lactamase: lessons from the mutagenesis of SER-130","volume":"278","author":"Helfand","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0090","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1128\/AAC.46.12.3971-3977.2002","article-title":"Amino acid substitutions at Ambler position Gly238 in the SHV-1 \u03b2-lactamase: exploring sequence requirements for resistance to penicillins and cephalosporins","volume":"46","author":"Hujer","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0095","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/AAC.49.7.2941-2948.2005","article-title":"Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 \u03b2-lactamase: defining a unique family of class C enzymes","volume":"49","author":"Hujer","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2217\/17460913.4.1.25","article-title":"Ceftaroline: a cephalosporin with expanded Gram-positive activity","volume":"4","author":"Kanafani","year":"2009","journal-title":"Future Microbiol"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0105","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1128\/AAC.00756-10","article-title":"Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-producing Enterobacteriaceae","volume":"55","author":"Livermore","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0110","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijantimicag.2011.01.012","article-title":"What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline","volume":"37","author":"Livermore","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0115","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/jac\/dkq115","article-title":"A tripeptide deletion in the R2 loop of the class C \u03b2-lactamase enzyme FOX-4 impairs cefoxitin hydrolysis and slightly increases susceptibility to \u03b2-lactamase inhibitors","volume":"65","author":"Mallo","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0120","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1074\/jbc.270.36.21428","article-title":"Molecular evolution of a class C \u03b2-lactamase extending its substrate specificity","volume":"270","author":"Nukaga","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0125","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/AAC.44.2.362-367.2000","article-title":"High-level expression of chromosomally encoded SHV-1 \u03b2-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae","volume":"44","author":"Rice","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0130","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1128\/AAC.02429-13","article-title":"Antimicrobial activity of ceftazidime-avibactam against Gram-negative organisms collected from U.S. medical centers in 2012","volume":"58","author":"Sader","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/nyas.12010","article-title":"New \u03b2-lactam-\u03b2-lactamase inhibitor combinations in clinical development","volume":"1277","author":"Shlaes","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0140","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1107\/S0907444901016274","article-title":"Crystallization and preliminary X-ray study of OXA-1, a class D \u03b2-lactamase","volume":"57","author":"Sun","year":"2001","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0145","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1128\/AAC.02123-13","article-title":"In vitro activities of ceftazidime-avibactam and aztreonam-avibactam against 372 Gram-negative bacilli collected in 2011 and 2012 from 11 teaching hospitals in China","volume":"58","author":"Wang","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.02.003_bb0150","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1021\/jm301490d","article-title":"Design and exploration of novel boronic acid inhibitors reveals important interactions with a clavulanic acid-resistant sulfhydryl-variable (SHV) \u03b2-lactamase","volume":"56","author":"Winkler","year":"2013","journal-title":"J Med Chem"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889315000371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889315000371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T19:08:54Z","timestamp":1566328134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889315000371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0732889315000371"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2015.02.003","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single \u03b2-lactamases","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2015.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}